Doctors at cardiology conference say Vytorin-cancer link can't be ruled out

MUNICH, Germany - Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday....More